GlaxoSmithKline

The World Health Organization (WHO) recommends the widespread use of a malaria vaccine among children in Africa and other areas with a high prevalence of malaria. This is a great success in the long struggle against the deadly disease.

The British-Swedish pharmaceutical company AstraZeneca has requested an extraordinary permit for the use in the United States of its latest drug, which prevents COVID-19 disease. The drug, currently called AZD7442, is intended for people with weak immune systems, which would make vaccination ineffective.

The pharmaceutical company AstraZeneca announced it was seeking authorization for usage in US of a medicine related to the treatment from coronavirus infection. The medicine is aimed to prevent Covid-19 for people who respond poorly or do not respond at all to vaccines because of a weakened immune system, Reuters reported.

GlaxoSmithKline will supply up to 220,000 treatments

International experts on Feb. 3 inspected a Chinese laboratory in Wuhan that some U.S. officials had suggested was the source of the coronavirus, as plans were firmed up to distribute vaccines to poorer nations.

Sanofi will fill and pack millions of doses of Pfizer's Covid-19 vaccine from July in an effort to help meet the huge demand for the US drugmaker's shots.

The French company will aim to help supply more than 100 million doses of the vaccine this year from its German plant in Frankfurt, CEO Paul Hudson told Le Figaro newspaper on Tuesday.

Britain has agreed to spend 3.7 billion pounds on Covid-19 vaccines and in most cases will bear the liability if claims are made against the pharmaceutical companies involved.

Greece's National Organisation for Medicines (EOF) announced it is recalling yet two more lines of an over-the-counter heartburn medication containing the drug ranitidine, over fears that production lines have been contaminated with the potential carcinogen N-nitrosodimethylamine, or NDMA.

Greece's EOF drug safety authority has recalled two widely used stomach acid blockers on the recommendation of the European and American authorities after laboratory tests found them to contain the potentially dangerous chemical NDMA (N-Nitroso-dimethylamine).

AtScale, the world leader in large data management, opened an office in Sofia. This is the first destination in which the California company moves internationally. The company aims to "bring order in the chaotic ocean of data" that businesses are working on. Customers on its platform for business intelligence are giants such as JPMorgan Chase, Toyota, Wells Fargo, GlaxoSmithKline.